Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00795704 · ClinicalTrials.gov registry record · Phase 2
Impact of Mulberry Leaf on Type 2 Diabetes
A Phase 2 study, sponsored by University of Mississippi Medical Center.
- Completed
- Registry status
- Phase 2
- Development phase
- 24
- Enrollment target
NCT00795704 is a Phase 2 study that has completed, run by University of Mississippi Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT00795704, a Phase 2 study, has completed, sponsored by University of Mississippi Medical Center.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 24 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate whether mulberry leaf extract will help control blood sugar in patients with type 2 diabetes. We also want to look at the safety of mulberry leaf extract in these patients.
Interventions
- DRUG Placebo
- DRUG Mulberry Leaf Extract
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2008-04 |
| Est. Completion | 2010-05 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00795704
The ClinicalTrials.gov registry entry for NCT00795704 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Mississippi Medical Center, which has 96 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT00795704 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00795704 about?
NCT00795704 is a clinical study titled "Impact of Mulberry Leaf on Type 2 Diabetes". The purpose of this study is to evaluate whether mulberry leaf extract will help control blood sugar in patients with type 2 diabetes. We also want to look at the safety of mulberry leaf extract in these patients.
What is the current status of trial NCT00795704?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 24 participants. The study started on 2008-04. Estimated completion is 2010-05.
What interventions are being tested in trial NCT00795704?
The interventions under investigation include: Placebo (DRUG), Mulberry Leaf Extract (DRUG).
Who is sponsoring clinical trial NCT00795704?
This trial is sponsored by University of Mississippi Medical Center, which has 96 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.